Established in August 2016, VivaVision biotech is an innovative pharmaceutical company. Since its establishment, the company has focused on the research and development of international leading innovative drugs for the treatment of ophthalmic diseases, and is committed to providing better and better treatment schemes for millions of patients with ophthalmic diseases. The company has an international first-class ophthalmic team, and has established a leading product R & D pipeline. Our pipeline product VVN001, VVN539, VVN461 are currently in clinical stage, and other ocular surface and fundus treatment products are in different stages of development. Since its establishment, it has become one of the most leading ophthalmic innovative drug research and development companies in China.